Log in to save to my catalogue

Is there still a room for improvement in antimicrobial use in a setting where use of broad-spectrum...

Is there still a room for improvement in antimicrobial use in a setting where use of broad-spectrum...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2649251498

Is there still a room for improvement in antimicrobial use in a setting where use of broad-spectrum antibiotics require approval of an infectious diseases physician?

About this item

Full title

Is there still a room for improvement in antimicrobial use in a setting where use of broad-spectrum antibiotics require approval of an infectious diseases physician?

Publisher

New York, USA: Cambridge University Press

Journal title

Infection control and hospital epidemiology, 2022-06, Vol.43 (6), p.802-804

Language

English

Formats

Publication information

Publisher

New York, USA: Cambridge University Press

More information

Scope and Contents

Contents

The authorization of carbapenems, ceftazidime, cefepime, piperacillin-tazobactam, polymyxins, quinolones (except oral forms), glycopeptide antibiotics (vancomycin and teicoplanin), daptomycin, and linezolid are restricted to ID specialists. Because of high rates of AMR of the pathogens in hospital-acquired infections at our institution, patients su...

Alternative Titles

Full title

Is there still a room for improvement in antimicrobial use in a setting where use of broad-spectrum antibiotics require approval of an infectious diseases physician?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2649251498

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2649251498

Other Identifiers

ISSN

0899-823X

E-ISSN

1559-6834

DOI

10.1017/ice.2022.81

How to access this item